|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/137 | |
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61P 25/00 |
| (11) | Patento numeris | 1626709 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04709870.2 |
| Europos patento paraiškos padavimo data | 2004-02-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-02-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-09-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/003821 |
| Data | 2004-02-10 |
| (87) | Numeris | WO 2004/071501 |
| Data | 2004-08-26 |
| (30) | Numeris | Data | Šalis |
| 445793 P | 2003-02-10 | US | |
| 473925 P | 2003-05-29 | US |
| (72) |
COUCH, Richard, A., US
MICHAELS, A. Shire Pharmaceutical Development Inc., US
HODGKINS, Paul, US
|
| (73) |
Shire Canada Inc.,
275 Armand Frappier Coulevard, Laval, QC H7V 4A7,
CA
|
| (54) | ENANTIOMERIC AMPHETAMINE COMPOSITIONS FOR THE TREATMENT OF ADHD |
| ENANTIOMERIC AMPHETAMINE COMPOSITIONS FOR THE TREATMENT OF ADHD |